These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23241031)

  • 1. Formulation development and evaluation of lamivudine controlled release tablets using cross-linked sago starch.
    Singh AV; Nath LK
    Expert Opin Drug Deliv; 2013 Feb; 10(2):173-82. PubMed ID: 23241031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of microwave assisted grafted sago starch as controlled release polymeric carrier.
    Singh AV; Nath LK
    Int J Biol Macromol; 2013 Sep; 60():62-8. PubMed ID: 23707750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of acetylated moth bean starch as a carrier for controlled drug delivery.
    Singh AV; Nath LK
    Int J Biol Macromol; 2012 Mar; 50(2):362-8. PubMed ID: 22210486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of chemically modified hydrophobic sago starch as a carrier for controlled drug delivery.
    Singh AV; Nath LK
    Saudi Pharm J; 2013 Apr; 21(2):193-200. PubMed ID: 23960835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances of starch-based excipients used in extended-release tablets: a review.
    Hong Y; Liu G; Gu Z
    Drug Deliv; 2016; 23(1):12-20. PubMed ID: 24833274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
    Le TC; Mateescu MA
    Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment.
    Dev RK; Bali V; Pathak K
    Int J Pharm; 2011 Jun; 411(1-2):142-51. PubMed ID: 21463667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of modified-release tablets of zolpidem tartrate by biphasic quick/slow delivery system.
    Mahapatra AK; Sameeraja NH; Murthy PN
    AAPS PharmSciTech; 2015 Jun; 16(3):579-88. PubMed ID: 25391273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Approach to Enhance the Solubility of Famotidine Tablet by Using Naturally Isolated Pear Starch.
    Anjali K; Manjul SP
    Recent Pat Drug Deliv Formul; 2018; 12(1):75-80. PubMed ID: 29303081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
    Abbas G; Hanif M
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
    Ali KA; Mukherjee B; Bandyopadhyay AK
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1742-9. PubMed ID: 23216220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.